Cargando…

Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France

BACKGROUND: The COVID-19 pandemic and the national lockdown implemented in France have disturbed populations’ health behavior and overwhelmed hospitals. Furthermore, infection to SARS-CoV-2 has been found to be directly associated with an increased risk of venous thrombosis (VT) and pulmonary emboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabet, A., Grave, C., Tuppin, P., Emmerich, J., Olié, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2022
Materias:
093
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710961/
http://dx.doi.org/10.1016/j.acvdsp.2021.09.201
_version_ 1784623277731217408
author Gabet, A.
Grave, C.
Tuppin, P.
Emmerich, J.
Olié, V.
author_facet Gabet, A.
Grave, C.
Tuppin, P.
Emmerich, J.
Olié, V.
author_sort Gabet, A.
collection PubMed
description BACKGROUND: The COVID-19 pandemic and the national lockdown implemented in France have disturbed populations’ health behavior and overwhelmed hospitals. Furthermore, infection to SARS-CoV-2 has been found to be directly associated with an increased risk of venous thrombosis (VT) and pulmonary embolism (PE). PURPOSE: This study aimed to analyze the impact of the COVID-19 pandemic on the epidemiology of hospitalizations for VT and PE in France – with a special focus on the first lockdown period – in terms of the rates of patients hospitalized in 2020 versus 2017–19, their characteristics, and related in-patient and 90-day case-fatality rates. A secondary objective aimed at describe the prevalence of COVID-19 among patients hospitalized with VT and PE, respectively. METHODS: All patients hospitalized with a diagnosis of VT and PE respectively in France between January and September (weeks 1–40) of each year from 2017 to 2020 were selected. Weekly incidence rates ratios (IRR) were computed to compare the rates of patients hospitalized between 2020 and 2017–2019. RESULTS: Compared with the 2017–2019 study period, the rates of patients hospitalized with a primary diagnosis (PD) of VT or PE in 2020 were significantly (50 and 40%, respectively) lower during weeks 12–13. By contrast, the rate of patients hospitalized with an associated diagnosis (AD) of PE during the country's first lockdown (weeks 12–19 of 2020) was twice as high as in the same period in 2017–2019, and even three times higher in week 13. The prevalence of COVID-19 in patients hospitalized with a PD of VT and PE, and in those hospitalized with an AD of VT and PE reached, respectively, 4.0, 9.6, 17.2 and 44.6 during the lockdown (weeks 12–19). Inpatients case-fatality rates in patients hospitalized with an AD of PE increased significantly during weeks 12–13. CONCLUSION: This study highlights significant changes in the epidemiology of hospitalized VT and PE induced by the COVID-19 pandemic.
format Online
Article
Text
id pubmed-8710961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-87109612021-12-28 Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France Gabet, A. Grave, C. Tuppin, P. Emmerich, J. Olié, V. Archives of Cardiovascular Diseases. Supplements 093 BACKGROUND: The COVID-19 pandemic and the national lockdown implemented in France have disturbed populations’ health behavior and overwhelmed hospitals. Furthermore, infection to SARS-CoV-2 has been found to be directly associated with an increased risk of venous thrombosis (VT) and pulmonary embolism (PE). PURPOSE: This study aimed to analyze the impact of the COVID-19 pandemic on the epidemiology of hospitalizations for VT and PE in France – with a special focus on the first lockdown period – in terms of the rates of patients hospitalized in 2020 versus 2017–19, their characteristics, and related in-patient and 90-day case-fatality rates. A secondary objective aimed at describe the prevalence of COVID-19 among patients hospitalized with VT and PE, respectively. METHODS: All patients hospitalized with a diagnosis of VT and PE respectively in France between January and September (weeks 1–40) of each year from 2017 to 2020 were selected. Weekly incidence rates ratios (IRR) were computed to compare the rates of patients hospitalized between 2020 and 2017–2019. RESULTS: Compared with the 2017–2019 study period, the rates of patients hospitalized with a primary diagnosis (PD) of VT or PE in 2020 were significantly (50 and 40%, respectively) lower during weeks 12–13. By contrast, the rate of patients hospitalized with an associated diagnosis (AD) of PE during the country's first lockdown (weeks 12–19 of 2020) was twice as high as in the same period in 2017–2019, and even three times higher in week 13. The prevalence of COVID-19 in patients hospitalized with a PD of VT and PE, and in those hospitalized with an AD of VT and PE reached, respectively, 4.0, 9.6, 17.2 and 44.6 during the lockdown (weeks 12–19). Inpatients case-fatality rates in patients hospitalized with an AD of PE increased significantly during weeks 12–13. CONCLUSION: This study highlights significant changes in the epidemiology of hospitalized VT and PE induced by the COVID-19 pandemic. Published by Elsevier Masson SAS 2022-01 2021-12-27 /pmc/articles/PMC8710961/ http://dx.doi.org/10.1016/j.acvdsp.2021.09.201 Text en Copyright © 2021 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 093
Gabet, A.
Grave, C.
Tuppin, P.
Emmerich, J.
Olié, V.
Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title_full Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title_fullStr Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title_full_unstemmed Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title_short Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
title_sort impact of the covid-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in france
topic 093
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710961/
http://dx.doi.org/10.1016/j.acvdsp.2021.09.201
work_keys_str_mv AT gabeta impactofthecovid19pandemicandanationallockdownonhospitalizationsforvenousthromboembolismandpulmonaryembolisminfrance
AT gravec impactofthecovid19pandemicandanationallockdownonhospitalizationsforvenousthromboembolismandpulmonaryembolisminfrance
AT tuppinp impactofthecovid19pandemicandanationallockdownonhospitalizationsforvenousthromboembolismandpulmonaryembolisminfrance
AT emmerichj impactofthecovid19pandemicandanationallockdownonhospitalizationsforvenousthromboembolismandpulmonaryembolisminfrance
AT oliev impactofthecovid19pandemicandanationallockdownonhospitalizationsforvenousthromboembolismandpulmonaryembolisminfrance